During the study period, researchers monitored the 524,817 participants who did not previously have a substance use disorder to see whether they developed alcohol, cannabis, cocaine, nicotine, opioid, or other substance use disorders
September 4, 2025: Texas AG Files Lawsuit Against Eli Lilly for Zepbound Prescribing Practices The Attorney General of Texas has sued Zepbound manufacturer Eli Lilly, accusing the company of using illegal practices to boost sales
The danger is taking an unfinished treatment without a verified product, a regulated dose, or a clinician managing the risks
But the clinical evidence gap is significant: no human trials, no FDA approval, and an unregulated market growing far ahead of the science
SOURCE: Sunlight